Lisa Ford

Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study

Michael Davidson, Robin Emsley, Michelle Kramer et al. · Schizophrenia Research · 2007 · 237 citations

Early Response, Psychotropic Medication, Patient Safety +8

Efficacy and Safety of Paliperidone Extended-Release Tablets: Results of a 6-Week, Randomized, Placebo-Controlled Study

Stephen R. Marder, Michelle Kramer, Lisa Ford et al. · Biological Psychiatry · 2007 · 219 citations

Drug Safety, Medicine, Clinical Trials +5

Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Topiramate for Migraine Prevention in Pediatric Subjects 12 to 17 Years of Age

Donald W. Lewis, Paul Winner, Joel R. Saper et al. · PEDIATRICS · 2009 · 148 citations

Safety and Tolerability of Oral Paliperidone Extended-Release Tablets in Elderly Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study With Six-Month Open-Label Extension

Andreas Tzimos, Michelle Kramer, Lisa Ford et al. · American Journal of Geriatric Psychiatry · 2007 · 90 citations

Psychiatry, Geriatrics, Elderly Patients +10

Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study

Isadora Lopes Alves, Lyduine E. Collij, Daniele Altomare et al. · Alzheimer s & Dementia · 2020 · 72 citations · Full text